HEXOKINASE II TRANSCRIPTION AS ANTIDIABETIC DRUGS

Information

  • Research Project
  • 2538956
  • ApplicationId
    2538956
  • Core Project Number
    R44DK049882
  • Full Project Number
    2R44DK049882-02
  • Serial Number
    49882
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/15/1995 - 29 years ago
  • Project End Date
    6/30/2000 - 24 years ago
  • Program Officer Name
    HARMON, JOAN T.
  • Budget Start Date
    9/30/1997 - 27 years ago
  • Budget End Date
    6/30/1999 - 25 years ago
  • Fiscal Year
    1997
  • Support Year
    2
  • Suffix
  • Award Notice Date
    9/27/1997 - 27 years ago

HEXOKINASE II TRANSCRIPTION AS ANTIDIABETIC DRUGS

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R44
  • Administering IC
    DK
  • Application Type
    2
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG3
  • Study Section Name
  • Organization Name
    OSI PHARMACEUTICALS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    UNIONDALE
  • Organization State
    NY
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    11553
  • Organization District
    UNITED STATES